doi: 10.1016/j.jgar.2020.10.004.
Epub 2020 Oct 29.
Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming "collateral effect"
Affiliations
- PMID: 33130024
- PMCID: PMC7598418
- DOI: 10.1016/j.jgar.2020.10.004
Item in Clipboard
Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming "collateral effect"
J Glob Antimicrob Resist.
2020 Dec.
Abstract
- •
COVID-19 patients have an exaggerated risk of acquiring BSI during ICU stay.
- •
The incidence of ICU-acquired BSI in COVID-19 patients is higher than that reported in European ICUs in the pre-COVID-19 period.
- •
The commonest aetiological agents of BSI were intestinal commensals.
- •
A high rate of acquisition of VRE colonisation was observed.
Similar articles
-
Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge.Infect Control Hosp Epidemiol. 2021 Jan;42(1):84-88. doi: 10.1017/ice.2020.368. Epub 2020 Jul 24. Infect Control Hosp Epidemiol. 2021. PMID: 32703320 Free PMC article.
-
Central line-associated bloodstream infections among critically-ill patients in the era of bundle care.J Microbiol Immunol Infect. 2017 Jun;50(3):339-348. doi: 10.1016/j.jmii.2015.07.001. Epub 2015 Jul 31. J Microbiol Immunol Infect. 2017. PMID: 26316008
-
Incidence of risk factors for bloodstream infections in patients with major burns receiving intensive care: A retrospective single-center cohort study.Burns. 2018 Jun;44(4):784-792. doi: 10.1016/j.burns.2017.12.009. Epub 2018 Feb 1. Burns. 2018. PMID: 29395408
-
Laboratory diagnosis of bacteremia and fungemia.Infect Dis Clin North Am. 2001 Dec;15(4):1009-24. doi: 10.1016/s0891-5520(05)70184-7. Infect Dis Clin North Am. 2001. PMID: 11780265 Review.
-
Bloodstream infections in haematology: risks and new challenges for prevention.Blood Rev. 2009 May;23(3):113-22. doi: 10.1016/j.blre.2008.10.003. Epub 2008 Nov 28. Blood Rev. 2009. PMID: 19046796 Review.
Cited by
-
Mucormycosis coinfection post-COVID-19 recovery: Early suspicion and prompt action.Natl J Maxillofac Surg. 2022 Aug;13(Suppl 1):S153-S158. doi: 10.4103/njms.NJMS_289_20. Epub 2022 Aug 20. Natl J Maxillofac Surg. 2022. PMID: 36393958 Free PMC article.
-
Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).Antimicrob Resist Infect Control. 2022 Mar 7;11(1):45. doi: 10.1186/s13756-022-01085-z. Antimicrob Resist Infect Control. 2022. PMID: 35255988 Free PMC article.
-
Bloodstream Infections in Intensive Care Unit during Four Consecutive SARS-CoV-2 Pandemic Waves.Antibiotics (Basel). 2023 Sep 14;12(9):1448. doi: 10.3390/antibiotics12091448. Antibiotics (Basel). 2023. PMID: 37760744 Free PMC article.
-
Co-infections observed in SARS-CoV-2 positive patients using a rapid diagnostic test.Sci Rep. 2021 Aug 11;11(1):16355. doi: 10.1038/s41598-021-95772-3. Sci Rep. 2021. PMID: 34381118 Free PMC article.
-
The diversity and outcome of post-covid mucormycosis: A case report.Int J Surg Case Rep. 2021 Nov;88:106522. doi: 10.1016/j.ijscr.2021.106522. Epub 2021 Oct 18. Int J Surg Case Rep. 2021. PMID: 34692373 Free PMC article.
References
-
- Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed: interim guidance. World Health Organization. Available at https://www.who.int/publications/i/item/10665-331495
-
- Siegel J.D., Rhinehart E., Jackson M., Chiarello L. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:S165–S193. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
